pantini_biopharm | Unsorted

Telegram-канал pantini_biopharm - Pantini Biopharm

865

Календарь FDA для американских компаний

Subscribe to a channel

Pantini Biopharm

$ALXO (18.14$)
🇺🇸 🕒 ср, 2 мар. 2022 г., 15:00:03 MSK
ALX Oncology Announces First Patient Dosed in ASPEN-06, a Phase 2/3 Study of Evorpacept for the Treatment of Patients with Advanced Gastric or Gastroesophageal Junction Cancer

SOUTH SAN FRANCISCO, Calif., March 02, 2022 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., ("ALX Oncology" or the "Company"), a clinical-stage immuno-oncology company developing therapies to block the CD47 checkpoint...

Читать полностью…

Pantini Biopharm

$HOOK (2.52$)
🇺🇸 🕒 ср, 2 мар. 2022 г., 15:00:03 MSK
HOOKIPA Pharma Announces Pricing of $75.0 Million Public Offering of Common Stock and Non-Voting Convertible Preferred Stock

NEW YORK and VIENNA, Austria, March 02, 2022 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ:HOOK), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced...

Читать полностью…

Pantini Biopharm

🇺🇸 🕒 ср, 2 мар. 2022 г., 15:00:03 MSK
BioIntelliSense and UAE-based Mubadala Health Establish Strategic Collaboration to Enable Continuous Care Model for Medical Grade Remote Monitoring and Management

DENVER and ABU DHABI, United Arab Emirates, March 02, 2022 (GLOBE NEWSWIRE) -- BioIntelliSense, Inc., a continuous health monitoring and clinical intelligence company, announced today its strategic collaboration with...

Читать полностью…

Pantini Biopharm

🇺🇸 🕒 ср, 2 мар. 2022 г., 15:00:03 MSK
BlueWillow Biologics and Medigen Vaccine Biologics Announce Positive Results for Intranasal COVID-19 Booster Candidate in Pre-clinical Studies

BW-1019 elicits mucosal immunity, stopping spread at the entry of the virus Intranasal booster following primary intramuscular vaccine series shown to be a successful follow-on solution BlueWillow Biologics, Inc., a...

Читать полностью…

Pantini Biopharm

$KZR (14.57$)
🇺🇸 🕒 ср, 2 мар. 2022 г., 15:00:02 MSK
Kezar Life Sciences to Participate in Cowen 42nd Annual Health Care Conference

Kezar Life Sciences, Inc. (NASDAQ:KZR), a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders, today announced that Noreen Roth Henig,...

Читать полностью…

Pantini Biopharm

$APLS (44.74$)
🇺🇸 🕒 ср, 2 мар. 2022 г., 15:00:02 MSK
Apellis Pharmaceuticals to Present at Upcoming Investor Conferences

WALTHAM, Mass., March 02, 2022 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), a global biopharmaceutical company and leader in complement, today announced that the company will participate in the...

Читать полностью…

Pantini Biopharm

$KMDA (5.75$)
🇺🇸 🕒 ср, 2 мар. 2022 г., 15:00:02 MSK
Kamada to Announce Fourth Quarter and Fiscal Year Ended December 31, 2021 Financial Results, and Host Conference Call on March 15, 2022

REHOVOT, Israel, March 02, 2022 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ & TASE: KMDA), plasma-derived biopharmaceutical company, today announced that it will release financial results for the fourth quarter and...

Читать полностью…

Pantini Biopharm

$SLN (19.83$)
🇺🇸 🕒 ср, 2 мар. 2022 г., 15:00:02 MSK
Silence Therapeutics to Report Fourth Quarter and Full Year 2022 Results on March 17, 2022

Silence Therapeutics plc, Nasdaq: SLN ("Silence" or "the Company"), a leader in the discovery, development and delivery of novel short interfering ribonucleic acid (siRNA) therapeutics for the treatment of diseases with...

Читать полностью…

Pantini Biopharm

$BHC (23.41$)
🇺🇸 🕒 ср, 2 мар. 2022 г., 14:59:05 MSK
Ortho Dermatologics Now Accepting Applications for 2022 Aspire Higher Scholarship Program

Students Impacted by Dermatologic Conditions Are Encouraged to Apply Through May 31, 2022 LAVAL, Quebec, March 2, 2022 /PRNewswire/ -- Bausch Health Companies Inc. (TSX:BHC) ("Bausch Health") and its...

Читать полностью…

Pantini Biopharm

⬇️ $SHC
🕒 ср, 2 мар. 2022 г., 14:54:27 MSK
Sotera Health downgraded to Equal Weight with $24 target at Barclays

Читать полностью…

Pantini Biopharm

$MOH (313.99$)
🇺🇸 🕒 ср, 2 мар. 2022 г., 14:50:08 MSK
Should You Buy Molina Healthcare, Inc. (MOH) in Health Care Plans Industry?

Molina Healthcare, Inc. (MOH) is the highest overall rated company in the Health Care Plans industry with an overall score of 84. MOH is up 39.94% so far this year after the company closed yesterday at $311.88. The...

👉 Show more

Читать полностью…

Pantini Biopharm

$ORGO (7.24$)
🇺🇸 🕒 ср, 2 мар. 2022 г., 14:49:47 MSK
Organogenesis' Q4 Profit Jumps More than 150% To $54M, Issues Solid FY22 Guidance

Organogenesis Holdings Inc's (NASDAQ: ORGO)

Читать полностью…

Pantini Biopharm

🐝 $RYTM
🕒 ср, 2 мар. 2022 г., 14:47:21 MSK
Rhythm Pharmaceuticals resumed with a Buy at Stifel

Читать полностью…

Pantini Biopharm

🇺🇸 🕒 ср, 2 мар. 2022 г., 14:47:05 MSK
Provident Healthcare Partners Wins Three Awards at the 13h Annual M&A Atlas Awards

BOSTON and NEW YORK, March 2, 2022 /PRNewswire/ -- Provident Healthcare Partners was the recipient of three awards at the 13th Annual America's M&A Atlas Awards.

Читать полностью…

Pantini Biopharm

$SGMO (5.88$)
🇺🇸 🕒 ср, 2 мар. 2022 г., 14:44:17 MSK
H.C. Wainwright Thinks Sangamo Biosciences' Stock is Going to Recover

In a report released today, Patrick Trucchio from H.C. Wainwright maintained a Buy rating on Sangamo Biosciences (SGMO – Research Report), with a price target of $25.00. The company's shares closed last Tuesday at $5.88,...

👉 Show more

Читать полностью…

Pantini Biopharm

$JNCE (7.35$)
🇺🇸 🕒 ср, 2 мар. 2022 г., 15:00:03 MSK
Jounce Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results

- Continued execution on two proof-of-concept clinical trials for JTX-8064 and Vopratelimab, INNATE and SELECT, with clinical data on track for 2022 - - JTX-1484, a new antagonist antibody targeting LILRB4, enters...

Читать полностью…

Pantini Biopharm

$ARFXF (0.09948$)
🇺🇸 🕒 ср, 2 мар. 2022 г., 15:00:03 MSK
ProMIS Neurosciences' PMN310 antibody demonstrates significant cognitive benefit in a mouse model of Alzheimer's disease

TORONTO, Ontario and CAMBRIDGE, Mass., March 02, 2022 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX:PMN) (OTCQB:ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics...

Читать полностью…

Pantini Biopharm

$EVLO (3$)
🇺🇸 🕒 ср, 2 мар. 2022 г., 15:00:03 MSK
Evelo Biosciences to Participate in Cowen 42nd Annual Health Care Conference

CAMBRIDGE, Mass., March 02, 2022 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (NASDAQ:EVLO), a clinical stage biotechnology company developing SINTAX™ medicines as a new modality of orally delivered treatments...

Читать полностью…

Pantini Biopharm

$TCRX (4.22$)
🇺🇸 🕒 ср, 2 мар. 2022 г., 15:00:03 MSK
TScan Therapeutics to Participate in Upcoming Investor Conferences

WALTHAM, Mass., March 02, 2022 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (NASDAQ:TCRX), a biopharmaceutical company focused on the development of T cell receptor (TCR) engineered T cell therapies (TCR-T) for the...

Читать полностью…

Pantini Biopharm

$QURE (17.48$) $CRBP (0.32$) $AKTX (1.36$)
🇺🇸 🕒 ср, 2 мар. 2022 г., 15:00:02 MSK
Akari Therapeutics Appoints Rachelle Jacques as President and Chief Executive Officer

NEW YORK and LONDON, March 02, 2022 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (NASDAQ:AKTX), a late-stage biopharmaceutical company focused on innovative therapeutics to treat orphan autoimmune and inflammatory...

Читать полностью…

Pantini Biopharm

$AXSM (30.98$)
🇺🇸 🕒 ср, 2 мар. 2022 г., 15:00:02 MSK
Axsome Therapeutics to Present at the Cowen 42nd Annual Health Care Conference

NEW YORK, March 02, 2022 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, today announced...

Читать полностью…

Pantini Biopharm

$PSTI (1.71$)
🇺🇸 🕒 ср, 2 мар. 2022 г., 15:00:02 MSK
Pluristem CEO Issues Shareholder Update

HAIFA, Israel, March 02, 2022 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (NASDAQ:PSTI) (TASE: PSTI), a leading biotechnology company, today issued an update to its shareholders from its Chief Executive Officer and...

Читать полностью…

Pantini Biopharm

$ENDP (2.41$)
🇺🇸 🕒 ср, 2 мар. 2022 г., 14:59:56 MSK
Barclays Downgrades Endo International to Underweight, Lowers Price Target to $2

Barclays analyst Balaji Prasad downgrades Endo International (NASDAQ:ENDP) from Equal-Weight to Underweight and lowers the price target from $5 to $2.

Читать полностью…

Pantini Biopharm

👍 $JAZZ
🕒 ср, 2 мар. 2022 г., 14:56:12 MSK
Jazz Pharmaceuticals' 2022 guidance looks conservative, says Morgan Stanley

Читать полностью…

Pantini Biopharm

$PFE (45.74$)
🇺🇸 🕒 ср, 2 мар. 2022 г., 14:51:24 MSK
Pfizer Granted FDA Breakthrough Therapy Designation For Respiratory Syncytial Virus Vaccine Candidate For Prevention Of RSVi In Infants From Birth Up To Six Months Of Age By Active Immunization Of Pregnant Women

Pfizer Inc. (NYSE:PFE) today announced that its respiratory syncytial virus (RSV) vaccine candidate, PF-06482077 or RSVpreF, received Breakthrough Therapy Designation from the US Food and Drug Administration (FDA) for...

Читать полностью…

Pantini Biopharm

🇺🇸 🕒 ср, 2 мар. 2022 г., 14:50:07 MSK
Is McKesson Corporation (MCK) Stock Near the Top of the Medical Distribution Industry?

McKesson Corporation (MCK) is the highest overall rated company in the Medical Distribution industry with an overall score of 81. MCK is up 56.43% so far this year after the company closed yesterday at $271.75. The...

👉 Show more

Читать полностью…

Pantini Biopharm

👍 $JAZZ
🕒 ср, 2 мар. 2022 г., 14:48:20 MSK
Jazz Pharmaceuticals price target lowered to $187 from $202 at BMO Capital

Читать полностью…

Pantini Biopharm

🔥 $PFE
🕒 ср, 2 мар. 2022 г., 14:46:42 MSK
Pfizer granted FDA Breakthrough Therapy Designation for PF-06482077

Читать полностью…

Pantini Biopharm

$PFE (45.74$)
🇺🇸 🕒 ср, 2 мар. 2022 г., 14:45:01 MSK
Pfizer Granted FDA Breakthrough Therapy Designation for Respiratory Syncytial Virus (RSV) Vaccine Candidate for the Prevention of RSV in Infants from Birth up to Six Months of Age by Active Immunization of Pregnant Women

Pfizer Inc. (NYSE:PFE) today announced that its respiratory syncytial virus (RSV) vaccine candidate, PF-06482077 or RSVpreF, received Breakthrough Therapy Designation from the US Food and Drug Administration (FDA) for...

Читать полностью…

Pantini Biopharm

$AMRN (3.19$) $ATEC (11.07$) $RIGL (2.51$)
🇺🇸 🕒 ср, 2 мар. 2022 г., 14:44:17 MSK
Analysts Are Bullish on These Healthcare Stocks: Alphatec Holdings (ATEC), Amarin (AMRN)

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Alphatec Holdings (ATEC – Research Report), Amarin (AMRN – Research Report) and Rigel (RIGL – Research Report) with bullish...

👉 Show more

Читать полностью…
Subscribe to a channel